S. KILIÇKAP Et Al. , "Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer," 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.23, Viyana, Austria, pp.220, 2012
KILIÇKAP, S. Et Al. 2012. Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer. 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Viyana, Austria), 220.
KILIÇKAP, S., ALTUN, A., Babacan, N. A., Ataseven, H., & TEMİZ, T., (2012). Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer . 37th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.220). Viyana, Austria
KILIÇKAP, SAADETTİN Et Al. "Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer," 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Viyana, Austria, 2012
KILIÇKAP, SAADETTİN Et Al. "Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Viyana, Austria, pp.220, 2012
KILIÇKAP, S. Et Al. (2012) . "Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Viyana, Austria, p.220.
@conferencepaper{conferencepaper, author={SAADETTİN KILIÇKAP Et Al. }, title={Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer}, congress name={37th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Viyana}, country={Austria}, year={2012}, pages={220} }